Mirati Therapeutics: Principle Scientist: 2020-78

Mirati Therapeutics:
Mirati Therapeutics, Inc. (NASDAQ: MRTX) is a publicly traded San Diego based, clinical stage biotechnology company dedicated to advancing novel oncol
San Diego, CA, United States